Iris Involvement in Primary Intraocular Lymphoma

2000 ◽  
Vol 44 (6) ◽  
pp. 518-526 ◽  
Author(s):  
Gisela Velez ◽  
Marc D de Smet ◽  
Scott M Whitcup ◽  
Michael Robinson ◽  
Robert B Nussenblatt ◽  
...  
Keyword(s):  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma

OCULAR SARCOIDOSIS MISDIAGNOSED AS PRIMARY INTRAOCULAR LYMPHOMA

Retina ◽  
2010 ◽  
Vol 30 (2) ◽  
pp. 310-316 ◽  
Author(s):  
ANDREA D. BIRNBAUM ◽  
WENDY HUANG ◽  
OZLEM SAHIN ◽  
HOWARD H. TESSLER ◽  
DEBRA A. GOLDSTEIN
Keyword(s):  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma ◽  
Ocular Sarcoidosis

Su.127. Eradication of Tumor Colonization and Invasion By a B-Cell Specific Immunotoxin in a Murine Model for Human Primary Intraocular Lymphoma (Piol)

2006 ◽  
Vol 119 ◽  
pp. S203
Author(s):  
Zhuqing Li ◽  
Mahesh Sankaranarayana ◽  
Baoying Liu ◽  
Chi-Chao Chan ◽  
DeFeng Shen ◽  
...  
Keyword(s):  
B Cell ◽  
Murine Model ◽  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma

scholarly journals Primary Intraocular Lymphoma in a Patient with Bilateral Epstein-Barr Virus Panuveitis

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Seyedeh Maryam Hosseini ◽  
Mojtaba Abrishami ◽  
Elham Barashki ◽  
Ghodsieh Zamani
Keyword(s):  
B Cell ◽  
Epstein Barr Virus ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Retinal Hemorrhage ◽  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma ◽  
Blurred Vision ◽  
Barr Virus ◽  
Epstein Barr

Purpose. Herein, we report a case of primary intraocular lymphoma (PIOL) with the first presentation of bilateral Epstein-Barr virus- (EBV-) associated panuveitis. Case Presentation. A 69-year-old male was referred with a three-day history of blurred vision and pain and redness in his left eye following cataract surgery. Examination revealed panuveitis, vitritis, and necrotizing retinitis with retinal hemorrhage. A month later, the right eye was also involved. Polymerase chain reaction-based analysis of the vitreous sample was positive for EBV, and cytological evaluation was compatible with the diagnosis of B-cell lymphoma. A significant improvement was observed following serial intravitreal rituximab and methotrexate injections. The central nervous system and lungs were involved after 6 months, and the patient expired despite systemic chemotherapy. Conclusion. There may be an association between EBV panuveitis and primary intraocular B-cell lymphoma.

scholarly journals The Future of Primary Intraocular Lymphoma (Retinal Lymphoma)

2009 ◽  
Vol 17 (6) ◽  
pp. 375-379 ◽  
Author(s):  
Chi-Chao Chan ◽  
Sylvain Fisson ◽  
Bahram Bodaghi
Keyword(s):  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma ◽  
The Future

Treatment of primary intraocular lymphoma with intravitreal methotrexate

2008 ◽  
Vol 52 (3) ◽  
pp. 167-174 ◽  
Author(s):  
Reika Sou ◽  
Nobuyuki Ohguro ◽  
Tetsuo Maeda ◽  
Yoshitsugu Saishin ◽  
Yasuo Tano
Keyword(s):  
Intraocular Lymphoma ◽  
Primary Intraocular Lymphoma

Influence of Hydrophobic Surface Modification of Chitosan Based Methotrexate (MTX) Micro Implants to Treat Intraocular Lymphoma

2013 ◽  
Author(s):  
Soumyarwit Manna ◽  
James J. Augsburger ◽  
Zelia M. Correa ◽  
Julio A. Landero ◽  
Rupak K. Banerjee
Keyword(s):  
Surface Modification ◽  
Sustained Release ◽  
Hydrophobic Surface ◽  
Intraocular Lymphoma ◽  
Therapeutic Dosage ◽  
Primary Intraocular Lymphoma ◽  
Rare Form ◽  
Chemotherapeutic Effect ◽  
Oncology Practice ◽  
Micro Implants

Primary intraocular lymphoma (PIOL) is a rare form of lymphoma which is encountered in ocular oncology practice. Most preferred treatment has been intravitreal MTX injections which do not have a long lasting chemotherapeutic effect due to rapid elimination of the drug. In this study, chitosan (CS) and polylactic acid (PLA) based intraocular implants are fabricated for different MTX loadings (10%, 25% and 40% w/w). The implants administer a therapeutic dosage of 0.2–2.0 μg/day of MTX over a period of a month. PLA coated CS-MTX implants can be used for sustained release of MTX, thereby improving the treatment of PIOL.

Sign in / Sign up

Export Citation Format

Share Document